140 related articles for article (PubMed ID: 34541940)
1. An Unusual Case of Desmoplastic Melanoma With Monster Cells Imitating an Atypical Fibroxanthoma.
Ríos-Martín JJ; Pérez-Pérez M; Umbría-Jiménez S; Moreno-Ramírez D; Vallejo-Benítez A
Int J Surg Pathol; 2022 May; 30(3):313-316. PubMed ID: 34541940
[TBL] [Abstract][Full Text] [Related]
2. 'Monster cell' melanoma with pulmonary metastasis and cyclin D1 amplification.
Hawryluk EB; Baran JL; Gerami P; Sepehr A
J Cutan Pathol; 2013 Jan; 40(1):61-5. PubMed ID: 23278726
[TBL] [Abstract][Full Text] [Related]
3. Performance Testing of RREB1, MYB, and CCND1 Fluorescence In Situ Hybridization in Spindle-Cell and Desmoplastic Melanoma Argues for a Two-Step Test Algorithm.
Weissinger SE; Frick M; Möller P; Horst BA; Lennerz JK
Int J Surg Pathol; 2017 Apr; 25(2):148-157. PubMed ID: 27899693
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
[TBL] [Abstract][Full Text] [Related]
5. Malignant Melanoma of the Nail Apparatus: A Fluorescence In Situ Hybridization Analysis of 7 Cases.
Romano RC; Shon W; Sukov WR
Int J Surg Pathol; 2016 Sep; 24(6):512-8. PubMed ID: 27185405
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma with monster cells showing massive cyclin D1 amplification.
Pouryazdanparast P; Newman M; Mafee M; Guitart J; Gerami P
Am J Dermatopathol; 2009 Jun; 31(4):402-3. PubMed ID: 19461251
[No Abstract] [Full Text] [Related]
7. Desmoplastic melanoma with sarcomatoid dedifferentiation.
Kiuru M; McDermott G; Berger M; Halpern AC; Busam KJ
Am J Surg Pathol; 2014 Jun; 38(6):864-70. PubMed ID: 24618614
[TBL] [Abstract][Full Text] [Related]
8. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation.
Morey AL; Murali R; McCarthy SW; Mann GJ; Scolyer RA
Pathology; 2009; 41(4):383-7. PubMed ID: 19404853
[TBL] [Abstract][Full Text] [Related]
11. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis.
Dika E; Fanti PA; Fiorentino M; Capizzi E; Neri I; Piraccini BM; Ravaioli GM; Misciali C; Passarini B; Patrizi A
Melanoma Res; 2015 Aug; 25(4):295-301. PubMed ID: 25933206
[TBL] [Abstract][Full Text] [Related]
12. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
13. Melanoma mimicking atypical fibroxanthoma: Report of an unusual case.
Wang Y; Guo Y
J Cutan Pathol; 2021 Dec; 48(12):1493-1496. PubMed ID: 34258786
[TBL] [Abstract][Full Text] [Related]
14. Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations.
Chraybi M; Abd Alsamad I; Copie-Bergman C; Baia M; André J; Dumaz N; Ortonne N
Hum Pathol; 2013 Sep; 44(9):1902-11. PubMed ID: 23664541
[TBL] [Abstract][Full Text] [Related]
15. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
[TBL] [Abstract][Full Text] [Related]
16. Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma.
Gammon B; Ali L; Guitart J; Gerami P
Am J Dermatopathol; 2012 Jul; 34(5):487-90. PubMed ID: 22456513
[TBL] [Abstract][Full Text] [Related]
17. [A silent-growing and fast-killing melanoma in a teenager].
Uguen A; Talagas M; Quintin-Roué I; Abasq C; Coat C; Charles-Pétillon F; De Braekeleer M; Marcorelles P
Ann Pathol; 2012 Aug; 32(4):254-8. PubMed ID: 23010398
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic application of cyclin D1 fluorescent in situ hybridization for histologically undetermined early lesions of acral melanoma in situ: A case series.
Cho-Vega JH; Cao T; Ledon J; Moller M; Avisar E; Elgart G; Tan JH; Fan YS; Grichnik JM
Ann Diagn Pathol; 2021 Feb; 50():151681. PubMed ID: 33341705
[TBL] [Abstract][Full Text] [Related]
19. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Nai G; Marques M
Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]